Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients

Journal of Translational Medicine

Oral Presentation

Francesco Colucci¹  Andrea Dominijanni²  Paolo A Ascierto³  Ester Simeone³  Mariaelena Capone³  Gabriele Madonna³  Domenico Mallardo³  Antonio M Grimaldi³  Rossana Tallerico⁴  Costanza M Cristiani⁴ 

[1] Department of Obstetrics and Gynaecology, University of Cambridge Clinical School, Cambridge, UK;Immunohaematological Transfusion Medicine Centre “Pugliese-Ciaccio” Hospital of Catanzaro, 88100, Ctanzaro, Italy;Melanoma. CancerImmunotherapy and Innovative Therapy Unit, Istituto Nazionale Tumori Fondazione "G. Pascale", 80131, Via Mariano SemmolaNapoli, Italy;Tumorimmunology and Immunopathology Laboratory, Department of Experimental and Clinic Medicine, University "Magna Graecia" of Catanzaro, Campus - Germaneto, 88100, Catanzaro, Italy;

关键词: Melanoma;    Metastatic Melanoma;    Melanoma Patient;    Ipilimumab;    Cell Immune Response;   

DOI  :  10.1186/1479-5876-13-S1-O8

来源: Springer

【 授权许可】

Unknown   
© Tallerico et al; licensee BioMed Central Ltd. 2015. This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.